Company · CIK 0000907654 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Oruka Therapeutics, Inc. · ORKA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 21, 5:38 pm EDT | Arjun AgarwalSenior Vice President, Finance | 533 | $95.75 | $51,035 | 14,219 | −3.61% | 10b5-1 |
| Sep 21, 2026 SForm 4 → | Sep 21, 4:57 pm EDT | Paul T QuinlanGeneral Counsel | 10,000 | $93.64 | $936,417 | 29,995 | −25.0% | 10b5-1 |
| Sep 21, 2026 MForm 4 → | Sep 21, 4:57 pm EDT | Paul T QuinlanGeneral Counsel | 10,000 | $7.80 | $78,000 | 39,995 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:18 pm EDT | Joana GoncalvesChief Medical Officer | 7,947 | $92.38 | $734,145 | 31,771 | −20.0% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 15, 7:18 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $7.32 | $51,240 | 39,718 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:15 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 2,452 | $95.71 | $234,681 | 923,128 | −0.26% | |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:14 pm EDT | Paul T QuinlanGeneral Counsel | 1,039 | $95.71 | $99,443 | 29,995 | −3.35% | |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:11 pm EDT | Laura Lee SandlerChief Operating Officer | 906 | $95.71 | $86,713 | 235,478 | −0.38% | |
| Sep 11, 2026 SForm 4 → | Sep 15, 7:17 pm EDT | Arjun AgarwalSenior Vice President, Finance | 10,019 | $92.43 | $926,010 | 14,752 | −40.4% | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 15, 7:17 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,459 | $15.88 | $150,175 | 24,771 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 6:36 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | $91.82 | $459,101 | 236,384 | −2.07% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:36 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | $7.80 | $39,000 | 241,384 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 6:35 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 75,000 | $91.83 | $6,887,484 | 925,580 | −7.50% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:35 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 75,000 | $7.80 | $585,000 | 1,000,580 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 MForm 4 → | Sep 21, 4:57 pm EDT | Paul T QuinlanGeneral Counsel | 10,000 | — | — | 79,996 | — | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 15, 7:18 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | — | — | 164,992 | — | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 15, 7:17 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,459 | — | — | 58,333 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:36 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | — | — | 74,996 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:35 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 75,000 | — | — | 1,553,513 | — | 10b5-1 |